Skip to content

Comparison of the effects of using bupivacaine liposomes for thoracic paravertebral nerve block versus serratus anterior plane block in pediatric funnel chest NUSS surgery: A randomized controlled trial

Comparison of the effects of using bupivacaine liposomes for thoracic paravertebral nerve block versus serratus anterior plane block in pediatric funnel chest NUSS surgery: A randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128843
Enrollment
Unknown
Registered
2026-07-27
Start date
2026-07-06
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain in children with funnel chest after NUSS surgery

Interventions

Experimental group:Anterior serratus muscle plane block
Control group:Paravertebral nerve block of the thoracic vertebrae

Sponsors

Guangzhou Women and Children's Medical Center,Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Age 12 to 18 2. ASA class I-II 3. First time having a funnel chest NUSS surgery 4. No cognitive impairment or mental illness

Exclusion criteria

Exclusion criteria: 1.Allergic to bupivacaine liposomes; 2.There is infection or trauma at the puncture site; 3.Abnormal coagulation function;

Design outcomes

Primary

MeasureTime frame
The dosage of sufentanil used for rescue analgesia;

Secondary

MeasureTime frame
FPS-R Pain Score;The duration of the initial use of the remedial analgesic distance technique after its completion;The dosage for using Merrill to alleviate pain;NRS pain score;The number of times the patient used the intravenous analgesia pump for self-administered analgesia;Whether to use nerve block for remedial analgesia;adverse reaction;

Countries

China

Contacts

Public ContactXu Yingyi

Guangzhou Women and Children's Medical Center,Guangzhou Medical University

513438980@qq.com+86 20 8133 0597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026